AstraZeneca cancer drug fails trail, shares drop The Anglo-Swedish drugmaker's cancer drug Recentin failed in a one on one late stage trial with Roche's Avastin in colorectal cancer patients…. Read more
Search here for the brightest and best company profiles in the sector from our comprehensive list.
- Free Subscription
- Read Now
- View Publications
- Back Issues